Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 0.67%-1.53B | ---- | 69.19%-1.54B | ---- | 57.93%-5.01B | ---- | -1,821.21%-11.9B | ---- | -47.18%691.59M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 76.23%-2.82M | ---- | 75.66%-11.85M | ---- | -11.66%-48.67M | ---- | 35.13%-43.59M | ---- | -53.35%-67.19M |
| Attributable subsidiary (profit) loss | ---- | -145.67%-4.82M | ---- | 30.57%-1.96M | ---- | -108.55%-2.83M | ---- | 256.91%33.04M | ---- | 11.17%-21.06M |
| Impairment and provisions: | ---- | 307.43%433.21M | ---- | -94.76%106.33M | ---- | -79.33%2.03B | ---- | 5,592.48%9.82B | ---- | -22.54%172.55M |
| -Other impairments and provisions | ---- | 307.43%433.21M | ---- | -94.76%106.33M | ---- | -79.33%2.03B | ---- | 5,592.48%9.82B | ---- | -22.54%172.55M |
| Revaluation surplus: | ---- | -77.93%4.72M | ---- | -78.35%21.37M | ---- | -55.25%98.72M | ---- | 913.39%220.58M | ---- | 83.44%-27.12M |
| -Other fair value changes | ---- | -77.93%4.72M | ---- | -78.35%21.37M | ---- | -55.25%98.72M | ---- | 913.39%220.58M | ---- | 83.44%-27.12M |
| Asset sale loss (gain): | ---- | 524.71%129.38M | ---- | 213.03%20.71M | ---- | -380.79%-18.32M | ---- | -576.38%-3.81M | ---- | 325.53%800K |
| -Loss (gain) from sale of subsidiary company | ---- | 19.06%2.8M | ---- | 116.14%2.35M | ---- | -18,529.11%-14.56M | ---- | 172.41%79K | ---- | --29K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 46.67%18.24M | ---- | 2,809.15%12.44M | ---- | 88.03%-459K | ---- | -391.26%-3.83M | ---- | 600.00%1.32M |
| -Loss (gain) from selling other assets | ---- | 1,728.54%108.34M | ---- | 279.27%5.93M | ---- | -5,698.25%-3.31M | ---- | 89.54%-57K | ---- | ---545K |
| Depreciation and amortization: | ---- | -25.15%213.9M | ---- | -46.84%285.76M | ---- | 23.47%537.52M | ---- | 106.75%435.35M | ---- | 131.73%210.57M |
| -Depreciation | ---- | -10.64%81.33M | ---- | 7.84%91.01M | ---- | -9.53%84.39M | ---- | 126.84%93.29M | ---- | 134.91%41.12M |
| -Amortization of intangible assets | ---- | -41.43%68.88M | ---- | -64.47%117.6M | ---- | 91.65%331.04M | ---- | 399.68%172.74M | ---- | 1,714.65%34.57M |
| Financial expense | ---- | 13.93%504.77M | ---- | -6.08%443.05M | ---- | -12.44%471.75M | ---- | 11.80%538.8M | ---- | 77.07%481.91M |
| Exchange Loss (gain) | ---- | -28.42%42.25M | ---- | -75.37%59.03M | ---- | 3,551.01%239.62M | ---- | 121.13%6.56M | ---- | -50.02%-31.06M |
| Special items | ---- | -447.29%-24.37M | ---- | -23.55%7.02M | ---- | -19.23%9.18M | ---- | -80.94%11.37M | ---- | -58.89%59.62M |
| Operating profit before the change of operating capital | ---- | 61.46%-236.42M | ---- | 63.70%-613.46M | ---- | -91.33%-1.69B | ---- | -160.06%-883.21M | ---- | -17.76%1.47B |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -109.68%-18.1M | ---- | 253.65%186.94M | ---- | 90.71%-121.67M | ---- | -444.93%-1.31B | ---- | 114.07%379.65M |
| Accounts payable increase (decrease) | ---- | 87.36%-45.31M | ---- | -677.83%-358.4M | ---- | 92.32%-46.08M | ---- | 19.86%-599.64M | ---- | -352.77%-748.27M |
| Special items for working capital changes | ---- | -72.26%96.92M | ---- | -51.79%349.41M | ---- | 62.59%724.78M | ---- | 250.27%445.76M | ---- | -557.36%-296.64M |
| Cash from business operations | ---- | 53.41%-202.91M | ---- | 61.55%-435.5M | ---- | 51.73%-1.13B | ---- | -391.38%-2.35B | ---- | 246.60%805.35M |
| Other taxs | ---- | 43.92%-5.1M | ---- | -336.37%-9.09M | ---- | 96.93%-2.08M | ---- | -48.13%-67.9M | ---- | 51.72%-45.83M |
| Interest received - operating | ---- | -76.23%2.82M | ---- | -75.66%11.85M | ---- | 11.66%48.67M | ---- | -35.13%43.59M | ---- | 83.37%67.19M |
| Special items of business | -32.76%-156.79M | ---- | -43.49%-118.11M | ---- | 88.78%-82.31M | ---- | -231.63%-733.46M | ---- | -33.13%557.23M | ---- |
| Net cash from operations | -32.76%-156.79M | 52.58%-205.19M | -43.49%-118.11M | 60.16%-432.75M | 88.78%-82.31M | 54.19%-1.09B | -231.63%-733.46M | -386.79%-2.37B | -33.13%557.23M | 236.05%826.71M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | --1.67M | ---- | ---- | ---- | ---- | ---- | ---- | -13.21%15.78M | -45.01%15.78M | -4.64%18.19M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 74.53%1.86M |
| Loan receivable (increase) decrease | -105.35%-292K | -110.33%-946K | 137.74%5.46M | 248.86%9.15M | -68.44%2.3M | 100.74%2.62M | 125.26%7.28M | -2,624.73%-353.29M | 77.78%-28.81M | -272.69%-12.97M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | 550.03%755.14M | 13,899.19%770.55M | -147.09%-167.8M | 97.54%-5.58M | 158.96%356.32M |
| Sale of fixed assets | 91.57%54.38M | -0.33%27.89M | 480.61%28.39M | 92.43%27.98M | 380.26%4.89M | 25.46%14.54M | -78.30%1.02M | 585.33%11.59M | 1,428.01%4.69M | 39.18%1.69M |
| Purchase of fixed assets | 97.84%-1.32M | 2.77%-11.92M | -519.09%-60.9M | 65.47%-12.26M | 36.06%-9.84M | 90.38%-35.51M | 76.31%-15.38M | -109.09%-369.19M | -254.28%-64.95M | 8.82%-176.56M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | 73.72%-170K | ---- | -124.65%-647K | 80.22%-18K | 98.78%-288K |
| Sale of subsidiaries | ---- | ---- | 243.48%4M | 99.68%-241K | 96.39%-2.79M | -130.99%-74.23M | -132.26%-77.28M | --239.52M | --239.52M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -102.47%-47.38M | 91.77%-59.81M | 16,543.10%1.92B |
| Recovery of cash from investments | 3,897.02%89.85M | 3,241.14%369.5M | --2.25M | -70.06%11.06M | ---- | -96.70%36.94M | -95.13%33.87M | -31.28%1.12B | -35.45%695.37M | 45.19%1.63B |
| Cash on investment | -55.38%1.61M | -71.49%-4.62M | -53.63%3.61M | ---2.69M | 11.05%7.78M | ---- | 100.46%7M | 85.98%-150.11M | -307.43%-1.54B | 54.35%-1.07B |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | --16.18M | ---- | ---- | ---- | -260.94%-1.08B |
| Net cash from investment operations | 948.44%145.9M | 1,051.31%379.9M | -836.45%-17.2M | -95.39%33M | -99.68%2.34M | 139.04%715.51M | 197.92%727.05M | -81.12%299.33M | -20.12%-742.52M | 168.48%1.59B |
| Net cash before financing | 91.95%-10.9M | 143.70%174.71M | -69.18%-135.3M | -7.85%-399.75M | -1,149.46%-79.98M | 82.11%-370.66M | 96.55%-6.4M | -185.90%-2.07B | -186.13%-185.29M | 182.53%2.41B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -99.43%409K | -49.50%224.29M | -65.67%72.09M | -19.44%444.15M | -71.68%209.96M | -78.86%551.33M | -62.12%741.47M | -45.87%2.61B | 77.12%1.96B | -14.50%4.82B |
| Refund | 37.85%-96.07M | -26.42%-658.04M | 45.40%-154.58M | 75.34%-520.51M | 85.13%-283.08M | 45.54%-2.11B | 33.14%-1.9B | -59.47%-3.88B | -227.92%-2.85B | -80.87%-2.43B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.92%1.35M | --1.11M | 1,084,142.57%1.6B |
| Interest paid - financing | 94.26%-4.95M | 60.35%-27.5M | -70.02%-86.28M | -7.64%-69.37M | -17.43%-50.75M | 85.54%-64.44M | 81.84%-43.21M | -18.61%-445.69M | 7.25%-237.92M | -155.95%-375.77M |
| Dividends paid - financing | ---- | ---- | ---- | -7.94%-22.27M | ---- | 90.41%-20.63M | ---- | 35.36%-215.07M | ---5.5M | 11.70%-332.69M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | -7.69%2.4M | ---- | -19.50%2.6M | -92.68%2.6M | 31.84%3.23M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 83.94%-8.64M | 63.52%-8.64M | 93.48%-53.76M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | 99.33%-38K | ---- | 88.79%-5.65M | 94.24%-2.9M | -240.99%-50.39M |
| Net cash from financing operations | 42.42%-110.77M | -136.31%-493.87M | -27.53%-192.38M | 88.04%-208.99M | 87.91%-150.85M | 15.13%-1.75B | -3.51%-1.25B | -167.19%-2.06B | -945.56%-1.21B | 5.54%3.06B |
| Effect of rate | -111.25%-193K | 111.29%2.13M | -68.82%1.72M | -97.97%1.01M | -86.73%5.5M | 170.42%49.77M | 221.95%41.46M | 72.24%-70.67M | -280.30%-34M | -871.86%-254.58M |
| Net Cash | 62.87%-121.67M | 47.57%-319.16M | -41.96%-327.68M | 71.26%-608.75M | 81.60%-230.83M | 48.72%-2.12B | 9.82%-1.25B | -175.43%-4.13B | -1,493.65%-1.39B | 29,285.01%5.48B |
| Begining period cash | -49.62%321.82M | -48.75%638.85M | -48.75%638.85M | -62.39%1.25B | -62.39%1.25B | -55.90%3.31B | -55.90%3.31B | 227.57%7.52B | 227.57%7.52B | 0.62%2.29B |
| Cash at the end | -36.09%199.96M | -49.62%321.82M | -69.36%312.88M | -48.75%638.85M | -51.41%1.02B | -62.39%1.25B | -65.49%2.1B | -55.90%3.31B | 152.41%6.09B | 227.57%7.52B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.